AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ATAZANAVIR & RITONAVIR
15 registrations across 5 African markets— 14 active
Markets with ATAZANAVIR & RITONAVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Atazor-R Tablets_ Tablet | 🇳🇬Nigeria | Emcure Nigeria Limited | active | Aug 2030 |
| Atazanavir and Ritonavir Tablets 300 mg/100 mg Tablet | 🇳🇬Nigeria | Jyna Pharma Ltd | active | May 2029 |
| RIZOMYL | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Nov 2027 |
| Atazanavir & Ritonavir Tablets 300 mg/100 mg Tablet | 🇳🇬Nigeria | Hetero Labs Nigeria Limited | active | Oct 2026 |
| Atazanavir (As Sulfate) And Ritonavir Tablets Tablet | 🇳🇬Nigeria | Healthline Limited | active | Nov 2025 |
| ATAZANAVIR&_RITONAVIR 300/100MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | EMCURE PHARMACEUTICA LS LTD | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | MYLAN LABORATORIES LIMITED | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY FILM-
COATED TABLETS | 🇺🇬Uganda | EMCURE PHARMACEUTICA LS LTD | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | MYLAN LABORATORIES LIMITED | active | — |
| ATAZOR R comprimé / 100 mg / 300 mg | 🇸🇳Senegal | EMCURE PHARMACEUTICALS LTD | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | MYLAN LABORATORIES LIMITED | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | EMCURE PHARMACEUTICA LS LTD | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY FILM-
COATED
TABLETS | 🇺🇬Uganda | EMCURE PHARMACEUTICA LS LTD | active | — |
| ATAZANAVIR +
RITONAVIR ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | MYLAN LABORATORIES LIMITED | active | — |
ATAZANAVIR & RITONAVIR in Africa — Regulatory Overview
ATAZANAVIR & RITONAVIR is registered across 5 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Nigeria, Malawi, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 15 registrations, 14 (93%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.